Cancer Research
Researchers from the United States and Japan report recent findings in cancer
Published in Gene Therapy Weekly, July 20th, 2006
Study 1: According to a study from the United States, engineering conditionally replication-competent adenoviral vectors carrying the Cyt deaminase (CD) gene increases the infectivity and therapeutic effect for breast cancer gene therapy.
"We constructed a conditionally replication-competent adenoviral vector Ad.Lp-CD-IRES-E1A(control) in which the expression of both the prodrug-activating CD gene and the viral replication E1A gene were driven by the L-plastin tumor-specific promoter," wrote Y. Liu and colleagues, Sidney Kimmel Cancer Center.
They...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-07-20)
More Articles from Gene Therapy Weekly
- Cancer Therapy
Proto-oncogene product directly controls cell cycle gene expression - Gene Transfer
Age-related vascular dysfunction lessened by extracellular superoxide dismutase - Neuroscience
Specific proteins are regulated in intact central nervous system - RNA Interference
Short interfering RNA mutation results in thermodynamically unstable duplex - West Nile Virus
West Nile virus replication inhibited using synthetic oligonucleotides - Allergy & Immunology
CD28 costimulation induces incomplete activation response in EBV-specific T cells - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
